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Abstract (300 words) 
Aim: The aims of this study were twofold: (a) to explore whether specific 
components of shared decision making were present in consultations 
involving nurse prescribers (NPs), pharmacist prescribers (PPs) and 
general practitioners (GPs) and (b) to relate these to self-reported patient 
outcomes including satisfaction, adherence and patient perceptions of 
practitioner empathy. 
Background: There are a range of ways for defining and measuring the 
process of concordance, or shared decision-making as it relates to 
decisions about medicines. As a result, demonstrating a convincing link 
between shared decision making and patient benefit is challenging. In the 
UK, nurses and pharmacists can now take on a prescribing role, engaging 
in shared decision-making. Given the different professional backgrounds 
of GPs, NPs and PPs, this study sought to explore the process of shared 
decision making across these three prescriber groups. 
Methods: Analysis of audio-recordings of consultations in primary care in 
South England between patients and GPs, NPs and PPs. Analysis of patient 
questionnaires completed post consultation.   
Findings: 532 consultations were audio-recorded with 20 GPs, 19 NPs and 
12 PPs. Prescribing decisions occurred in 421 (79%). Patients were given 
treatment options in 21% (102/482) of decisions, the prescriber elicited 
the patient’s treatment preference in 18% (88/482) and the patient 
expressed a treatment preference in 24% (118/482) of decisions. PPs 
were more likely to ask for the patient’s preference about their treatment 
regimen (X2=6.6, p=0.036, Cramer’s V=0.12) than either NPs or GPs. Of 
the 275 patient questionnaires, 192(70%) could be matched with a 
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prescribing decision. NP patients had higher satisfaction levels than 
patients of GPs or PPs. More time describing treatment options was 
associated with increased satisfaction, adherence and greater perceived 
practitioner empathy. While defining, measuring and enabling the process 
of shared decision making remains challenging, it may have patient 
benefit. 
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Introduction 
This paper presents research which sought to explore the process of 
concordance amongst general practitioners, nurse and pharmacist 
prescribers in primary care in the UK. Concordance has been defined as 
occurring when “the patient and the healthcare professional participate as 
partners to reach an agreement on when, how and why to use medicines 
drawing on the expertise of the health care professional as well as the 
experiences, beliefs and wishes of the patient” (Royal Pharmaceutical 
Society of Great Britain, 1997). Although there has been some confusion 
about the meaning of concordance (Jordan, Ellis and Chambers, 2002), it 
bears a strong similarity to the process of shared decision making as 
described by Charles, Gafni and Whelan (1997). Indeed a conceptual 
review of shared decision making found 31 separate concepts to describe 
the process, although only two concepts, patient values / preferences and 
giving options, appeared in more than half of the definitions (Makoul and 
Clayman, 2006). Concordance resonates strongly with these concepts 
and, it is argued here, is seen as being consistent with a shared decision 
making approach where at least one of the treatment options involves a 
medicine. 
 
Aided by a politically driven ideology endorsing patient centred 
communication as being synonymous with good patient care, of which 
shared decision making is a part (de Haes, 2006), research involving 
shared decision making has increased dramatically in recent years. With 
this increase has come the development of a wide range of instruments to 
assess the process of shared decision making. Systematic and structured 
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literature reviews have considered instruments which assess the 
physician’s perception of the decision making process (Légaré et al., 
2007), those that use direct or indirect observation of consultations that 
involve choices (Elwyn et al., 2001) and a review which has evaluated 
instruments exploring the decision making process (Dy, 2007). The 
reviewed measures came in a variety of formats: observer completed, 
using patient or health care professional report and using questions, 
rating scales, checklists or the presence/absence of defined behaviours. 
More recently, the need to capture both patient and professional 
perspectives in shared decision making (dyadic measures) has emerged 
as an important issue in measurement (Légaré et al., 2012).  
 
The range of definitions of shared decision making and the diverse range 
of measures has meant that determining the impact of shared decision 
making on outcomes has been difficult. Researchers have examined 
different aspects of the communication involved in shared decision making 
and then measured these effects in different ways. One review took a 
concordance perspective to investigate two-way communication about 
medicines between patients and professionals (Stevenson et al., 2004). 
They found that professionals rarely asked the patient their preference for 
a particular medicine, tended not to discuss their ability to adhere and did 
not always encourage patients to ask questions about their medicines 
(Stevenson et al., 2004). Another systematic review investigated the 
effects of shared decision-making on patient satisfaction, adherence and 
health status (Joosten, et al., 2008). Of the 11 included studies which 
compared a shared decision making intervention with a control 
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intervention, five demonstrated no benefit and in the remaining six, only 
one demonstrated an increase in patient satisfaction. Improvement in 
well-being was demonstrated in two studies, with improved adherence in 
one. The authors concluded that shared decision making may be most 
beneficial in chronic conditions and where a shared decision making 
intervention contains more than one session (Joosten, et al., 2008), a 
conclusion supported in a recent randomised controlled trial involving 
shared decision making in asthma (Wilson et al., 2010). While there is a 
continued need for more evidence on the impact of shared decision 
making on patient outcomes, the health policy agenda advocating 
informed patient choice and patient-centredness remains strong. 
Increasingly the implementation of shared decision making involves the 
use of decision aids to provide evidence-based information to support 
patient decision making (Elwyn, et al., 2010).     
 
In the UK, due to the expansion of prescribing to new prescribers (other 
than doctors and dentists), other health professionals have now also 
entered the frame of this debate. Although nurses had been able to 
prescribe from a limited formulary earlier before 2004, it was at this time 
that legislative changes were introduced to enable supplementary 
prescribing, described as ‘a voluntary partnership between the responsible 
independent prescriber (a doctor or a dentist) and a supplementary 
prescriber (nurse or pharmacist) to implement an agreed patient specific 
clinical management plan with the patient’s agreement’ (Department of 
Health, 2005, pp.11). Although this paper focuses specifically on nurse 
and pharmacist prescribing, the authority to prescribe (within their clinical 
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competence) has also been extended to include optometrists, 
physiotherapists, podiatrists and radiographers. Since 2006 nurses and 
pharmacists have been able to become full independent prescribers for 
any medical condition upon completion of an approved training course. As 
an independent prescriber, they are able to assess, and be responsible 
for, “patients with undiagnosed or diagnosed conditions and for decisions 
about the clinical management required, including prescribing” 
(Department of Health, 2006). Within this role, nurse and pharmacist 
(supplementary and independent) prescribers, like their doctor 
counterparts, are responsible for prescribing decisions and take on a key 
role in shared decision making during their consultations with patients 
(Bond, Blenkinsopp and Raynor, 2012). To this end, the National 
Prescribing Centre (now part of the National Institute for Health and Care 
Excellence) has identified a core set of nine prescribing competencies, 
initially developed for new prescribers such as nurses and pharmacists, 
but now applicable to all prescribers including doctors (National 
Prescribing Centre, 2012). Statements associated with the activities or 
outcomes that (good) prescribers should demonstrate within the shared 
decision making competency are shown in Table 1. This research focuses 
on the questioning skills associated with competencies 7 and 8 and the 
outcomes related to competencies 5, 9 and 13 (Table 1). 
 
Nurse and pharmacist prescribers come from a different educational 
tradition to doctors with regard to their basic training before they became 
prescribers. Historically, doctors have had sole control over the prescribing 
process and although concerns have been expressed that this dominance 
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could be diminishing (Britten, 2001; Willis, 2006), more recent studies 
have suggested that nurse and pharmacist prescribers have not 
challenged the dominance of medicine in their new role as prescribers 
(Weiss and Sutton, 2009; Cooper et al., 2011). Given the different 
educational, professional and sociological roots of doctors, nurse 
prescribers and pharmacist prescribers, this study sought to explore the 
process of shared decision making across these three prescriber groups. 
For example, due to different perceived levels of professional status 
(Charles-Jones, Latimer & May, 2003; Cooper et. al, 2008), would 
patients find it easier to express a treatment preference to a nurse or 
pharmacist prescriber? Would pharmacists, due to their professional focus 
on medicines, find it easier to discuss treatment rationales or medication 
options? The aim of this study was to explore the process of how nurse 
prescribers (NPs), pharmacist prescribers (PPs) and general practitioners 
(GPs) negotiated medication decisions in their interactions with patients, 
in particular, exploring specific components of shared decision making. 
Specific research objectives were to compare GPs, NPs and PPs with 
respect to: 
• Whether treatment options were offered  
• Whether the patient’s view about treatment options was elicited  
• Whether different treatment decision characteristics were related to 
patient outcomes such as satisfaction, adherence and perceived 
practitioner empathy.     
 
Methods 
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Theoretical Framework 
To evaluate the effect of whether shared decision making influences 
patient outcomes, audio-recordings of prescriber-patient consultations 
were coded by researchers to assess aspects of the prescribing decision 
making process such as whether treatment options were offered by the 
prescriber and whether the patient’s view was elicited about options. 
These findings were then related to a range of patient outcomes such as 
patient satisfaction, empathy, perception of role in decision making and 
adherence captured on a self-completed questionnaire. The theoretical 
rationale behind this investigation was that doctors’ use of collaborative 
communication when setting treatment goals has been associated with 
improved patient outcomes (Naik et al., 2008). As noted by Street et al. 
(2009), consultation communication can affect patient outcomes directly 
or, more probably, through proximal outcomes such as satisfaction, 
adherence or perceptions of empathy. Yet, methodologically, to 
investigate these relationships is challenging. The way statements or 
questions are constructed in an interaction are influenced by the specific 
medical and social context and, importantly, follow a sequence influenced 
by previous statements or questions in the interaction (Heritage, 2010). 
As such, any attempt at sense making of consultation recordings is 
inherently interpretive: an attempt by the researcher to attach meaning to 
an interaction with which they were not involved. This will result in 
interpretations influenced by the researcher’s own attitudes, perspectives 
and experiences. Nonetheless, while there is a core interpretative element 
to coding consultation data, the overall research approach follows a post-
positivist design which assesses causes that influence outcomes (Creswell, 
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2009). This is done through careful measurement of an objective reality 
(patient-prescriber consultations) and its effect on behaviours or views 
(patient self-report of outcomes on questionnaires). While the methods 
used are mixed (observation and questionnaires), our approach follows a 
practice mixed methods perspective, where methods emerge ‘bottom up’ 
to address pragmatic research questions (Creswell & Tashakkori, 2007).   
 
The Consultations 
Following NHS ethical approval, research and development permission was 
obtained in 36 Primary Care Trusts across southern and central England 
and Wales. GPs, nurse and pharmacist prescribers were recruited with the 
support of local Primary Care Research Networks (PCRNs). The PCRNs 
recruited research-active practices locally through newsletters, the PCRN 
website and reminder electronic emails lists. The research officers (JP, RR) 
visited interested practices and gave them more information about the 
study. Due to the nature of recruitment, it was not possible to calculate an 
overall response rate for recruited professionals. 
 
All consenting health professionals saw patients in a consulting room and 
were provided with an audio recorder. They were asked to record 
consultations with consenting patients. Patients received a patient 
information sheet either through the post or on arrival for their 
appointment. Consent from patients was obtained in the waiting room 
prior to their appointment. Included patients had to be over 16 and able 
to give their informed consent. In an effort to exclude consultations where 
a medicine decision was unlikely, patients were asked if they thought their 
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consultation might involve a discussion about a medicine. While not every 
patient knew if a medicine were to be discussed, it was possible to exclude 
particular consultations where a medicine discussion was clearly unlikely 
(e.g. antenatal appointment, new patient to practice, hospital post 
operative review). At the time of consent patients were also given a 
patient questionnaire with a pre-paid envelope to complete and return 
after their consultation. Patients were asked to state the number on the 
envelope at the beginning of the consultation so that consultation 
recordings could be matched to returned patient questionnaires. 
 
Audio-Recordings 
The research team analysed the audio-recordings using a data collection 
form based on the previous work of Chewning et al. (2006) who had 
developed a consultation coding protocol using the Concordance Coding 
Tool (CONNECT). The data collection form focused on medication / 
treatment decision making and examined decision making activities, their 
duration and sequence. Minor modifications to the data collection form 
were made following discussion amongst the three researchers (JP, RR, 
MW). Consultations were not fully transcribed but “coded” for specific 
issues. Particular variables and their respective coding categories used in 
this analysis are shown in Table 2. 
 
The Patient Questionnaire 
The patient questionnaire consisted of five main elements: satisfaction, 
patient preference for role in decision making, adherence, empathy and 
the amount of medicines information received. Satisfaction used a 
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previously validated satisfaction scale which was rated on a 5-point Likert 
rating scale from strongly agree to strongly disagree (Baker 1990). A 
standard patient preference scale for measuring involvement in decision 
making scale (Degner and Sloan, 1992) was used. This used a five-point 
scale ranging from an active to a shared to a passive role in decision 
making. This was asked three times: in relation to their preferred role ‘in 
general’ with the doctor, their actual experience with the prescriber they 
saw and their preference with a nurse prescriber (for NP patients), with a 
pharmacist prescriber (for PP patients) or with a chemist (for GP patients) 
as it was considered that GP patients would be more likely to have 
experience of seeing a chemist than a nurse or pharmacist prescriber. 
Adherence was measured using four self-reported adherence statements 
using the Reported Adherence to Medication scale which uses two 5-point 
Likert scales (Horne, Weinman and Hankins, 1999). Empathy was 
measured using the ten statements from the CARE empathy scale 
(Mercer, et. al., 2004) and there were three questions from the Local 
Health Services Questionnaire from NHS Surveys about the amount of 
medicine information received (Martin, 2008). Patients were also asked to 
provide demographic information. Further details of the questionnaire are 
available on request. 
 
In accordance with Baker (1990), the satisfaction scale consisted of 18 
statements or items which were divided into 3 sub-scales and a general 
satisfaction scale (Table 3). It was considered that some of the 
statements might not be relevant for some patients and therefore, unlike 
the original Baker satisfaction scale, patients were allowed to tick a ‘not 
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applicable’ box. Upon return of the questionnaires, there were a large 
number of items ticked ‘not applicable’ by patients which would have 
resulted in the loss of response from 22 – 82 patients (out of 275), 
depending on the satisfaction sub scale (using listwise deletion). For this 
reason, satisfaction questionnaires were coded such that a patient’s mean 
response was calculated based on the number of items within a sub-scale 
which were completed (so if only 4 out of 5 statements within a sub-scale 
were completed, the mean response was calculated for 4 statements). 
This led to a higher number of usable questionnaires (11 to 17 cases 
missing, depending on the sub scale) although those where there was 
genuine missing data were still deleted.  
 
Data Analysis 
Data were entered into PASW v18 for analysis. Data were initially 
analysed descriptively. Due to the skewed nature of data distribution, 
differences between prescriber groups were analysed using a Kruskal 
Wallis test. Associations between decision process variables and 
demographic data were analysed using appropriate non-parametric tests 
with a p value < 0.05 taken as significant. Multiple regression was used to 
investigate the effect of key decision process and demographic variables 
on patient satisfaction, patient self-reported adherence and patient 
perception of practitioner empathy.  
 
Results 
There were 51 prescribers recruited over the period from October 2009 to 
September 2011. These comprised 20 GPs, 19 nurse prescribers and 12 
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pharmacist prescribers from 36 practices in 14 Primary Care Trusts (PCTs) 
in England (Table 4). Consultations included patients presenting with 
acute conditions (e.g. chest, throat, urinary infections, acute pain due to 
injury, skin conditions) and those with new or managed chronic conditions 
(e.g. hypertension, diabetes, asthma, depression and cardiovascular 
conditions). Prescribers worked in either an open clinic (any condition but 
more likely to be acute conditions) or condition-led clinic dealing with 
chronic conditions (e.g. hypertension, diabetes). Open clinics accounted 
for 72% (383/533) of the consultations (210/383, 55% by GPs, 173/383, 
45% by NPs, 0% by PPs). Condition-led clinics accounted for 28% 
(150/533) of the consultations recorded (3/150, 2% by GPs, 36/150, 24% 
by NPs and 111/150, 74% by PPs). With a median consultation length of 
15.75 minutes (Table 4), pharmacists had significantly longer 
consultations than either GPs (9.96 minutes) or NPs (9.92 minutes) [K-W 
x2(2,533)=62.1, p<0.0001].  
 
Prescribing Decisions 
 
Of the 533 consultations recorded, 421 (79%) involved a prescribing 
decision with most, 366 (87%)involving one prescribing decision (Table 
5). Of the 482 prescribing decisions, 223 (46%) were made in GP 
consultations, 159 (33%) in NP consultations and 100 (21%) in PP 
consultations. Examples of the types of decisions made during these 
consultations are provided in Table 6. 
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Patients were given medication / treatment options in 21% of prescribing 
decisions, were provided with a rationale for a proposed medication (pre-
decision) in 28% of decisions, the prescriber elicited the patient’s 
preference for treatment in 18% of decisions and the patient expressed a 
treatment preference in 24% of prescribing decisions (Table 7). When a 
treatment preference was expressed, it was usually (87/118, 74%,) 
adopted by the prescriber. The patients that expressed a preference that 
the prescriber adopted were more likely to give a positive response to the 
prescriber’s treatment decision compared with those whose prescriber did 
not adopt the patient’s preference (X2 (24,117) = 40.2, p=0.02, Cramer’s 
V=0.29). In the majority of prescribing decisions (74%), the patient asked 
no questions, with one question being asked in 102 (21%) of prescribing 
decisions.  
 
Twelve out of 20 of the GPs were male and four out of the 12 pharmacist 
prescribers were male. All of the nurse prescribers were female. 
Consultations with female GPs were more likely than those with male GPs 
to elicit the patient’s preference about treatment (31/103, 30% of 
consultations involving female GPs vs 12/119, 10% of consultations 
involving male GPs; X2 (1,222) = 14.2, p<0.001, phi=0.25). 
 
As shown in Table 7, pharmacist prescribers were more likely to ask the 
patient for their preference about the medication regimen than either NPs 
or GPs (X2 (2, 482) = 6.6, p=0.036, Cramer’s V=0.12). They were also 
more likely to provide treatment options than either GPs or NPs (X2 (2, 
482) = 9.5, p=0.009, Cramer’s V=0.14). However, patients were more 
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likely to ask questions in GP consultations compared with NP or PP 
consultations (X2 (2, 478) = 7.73, p=0.021, Cramer’s V=0.13). Other 
variables (patient expressing a medication / treatment preference or 
prescriber providing a rationale for a medication / treatment pre-decision) 
were not significantly different across prescriber groups (Table 7). 
 
Patient Questionnaires 
 
There were 275 (out of 532, response rate 51%) returned patient 
questionnaires. There were 117 from GP patients, 101 from nurse 
prescriber patients and 57 from pharmacist prescriber patients (Table 8). 
Of the 275 patients, 63% were female and 99% were White / British. 
Patients had a mean age of 59 (SD=17.7) and the majority (56%) left 
full-time education age 16 or less. As shown in Table 8, pharmacist 
prescribers saw significantly more male patients than nurses or GPs (X2 
(2, 273) = 12.6, p=0.002, Cramer’s V=0.22), their patients were also 
more likely to be older [X2 = 27.0, df=2, p<0.0001] and to have left 
school at age 16 or less [X2 (2, 272) = 19.6, p=0.003, Cramer’s V=0.19]. 
 
In addition to asking their experiences with the prescriber they saw, all 
patients were asked what role in treatment decision making they prefer in 
general with their doctor. Forty four percent (121) preferred an active or 
collaborative role in decision making with 154 (56%) preferring a more 
passive role. Age was related to decision making preference such that 
older patients were more likely to prefer that the doctor made the decision 
[Spearman’s rho=0.17, p=0.006]. Patient gender was also associated 
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with role preference such that women were more likely to prefer a more 
active role in decision making than men [X2 (2, 273) = 11.44, p=0.003, 
Cramer’s V=0.205]. For NP and PP patients, patient preference for 
involvement did not significantly change when asked for their preference 
with regards to a doctor or a nurse or pharmacist prescriber suggesting 
that the patient’s preference for involvement in decision making does not 
vary with prescriber type. It was possible to compare the patient’s 
expectations of their prescriber with regards to who should make the 
decision with what they actually experienced in the consultation. For 
example, NP patients were asked for their expectations of who should 
make the decision with a NP and this compared with what they actually 
experienced in the consultation. For the majority of patients (66%, 
176/266), their expectations for their role in decision making (active, 
shared or passive) matched what they received in the consultation. There 
was no difference on any of the satisfaction scales between those whose 
expectations matched their actual experience and those whose did not.  
 
There was a high level of patient self-reported adherence with 62% 
(158/255) disagreeing or strongly disagreeing that they had difficulties 
taking their medicines. Overall ratings of practitioner empathy were high 
with a mean (SD) score of 43 (7.4) out of a total possible score of 50 
(N=207). There was no difference in patient self-reported adherence or 
patient perceptions of practitioner empathy across the prescriber groups.   
 
All of the self reported patient outcomes (satisfaction, adherence and 
empathy) were explored in relation to each other, to prescriber type and 
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to consultation length. Median satisfaction scores, with higher values 
indicating greater satisfaction, were 4.33 for general patient satisfaction 
(N=262), 4.14 for professional care (N=260), 3.60 for depth of 
relationship (N=258) and 4.0 for perceived time (N=254). A Kruskal 
Wallis Test revealed a statistically significant relationship in the general 
satisfaction and professional care scales across the three prescriber 
groups, with nurse prescribers receiving a higher level of patient 
satisfaction than patients of GPs or pharmacist prescribers [X2 = 12.88, 
df=2, p=0.002 for General Satisfaction; X2 = 6.85, df=2, p=0.03 for 
Professional Care]. Median and mean satisfaction scores and their values 
across the different prescriber groups are shown in Table 9. Consultation 
length was unrelated to satisfaction, adherence or empathy (Table 10). 
Patient satisfaction was similarly unrelated to adherence, although higher 
perceptions of practitioner empathy were significantly associated with 
increased patient satisfaction on all four of the satisfaction scales (Table 
10). All patient satisfaction scales were correlated with each other.  
 
Relating Prescribing Decisions to Patient Outcomes 
 
In consultations where prescribing decisions were made, most (87%) 
involved one prescribing decision (366/421). For ease of analysis, if more 
than one prescribing decision was made in a consultation, only the first 
prescribing decision was related to patient questionnaire data. However it 
is recognised that in consultations where more than one decision was 
made, the patient could have completed the questionnaire in relation to 
other decisions made in the consultation. Of the 275 returned patient 
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questionnaires, 192 of these could be matched with a corresponding 
prescribing decision. Although, as noted above, consultation length was 
unrelated to any of the patient outcomes, it was considered that length of 
time spent describing treatment options might be a more accurate 
measure of shared decision making process which could be relevant to 
patient outcomes. It was found that the more time spent by the prescriber 
describing treatment options in the consultation was significantly 
associated with increased general satisfaction [Spearman’s rho=0.29, 
p=0.05], professional care [Spearman’s rho=0.41, p=0.005] and depth of 
care satisfaction [Spearman’s rho=0.35, p=0.017]. Increased time 
describing treatment options was also associated with increased patient 
adherence [Spearman’s rho=-0.3, p=0.05] and greater perceived 
prescriber empathy by the patient [Spearman’s rho=0.46, p=0.004]. The 
length of time spent describing treatment options was not related to 
prescriber type. Variables created from the prescribing decision data 
(Table 2) along with prescriber and patient demographic information were 
entered into a multiple regression equation using the following dependent 
variables: patient satisfaction scales, patient self-reported adherence and 
patient perceptions of practitioner empathy. None of the variables 
significantly predicted the dependent variables, with all models explaining 
a low level of variance (less than 20%). 
 
Discussion 
This study explored how nurse prescribers, pharmacist prescribers and 
general practitioners, in their consultation interactions with patients, made 
treatment decisions and related this to several self-reported patient 
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outcomes. The findings suggest that concordance, or shared decision 
making with regards to medicine taking, is only occurring to a limited 
extent; in only a quarter of consultations were patients given treatment 
options or provided a rationale for a proposed medication / treatment 
(Table 7). In only a fifth of consultations did the prescriber elicit the 
patient’s preference for treatment and in a quarter did the patient express 
a treatment preference. This is despite the suggestive evidence found in 
this study that spending longer discussing treatment options was 
associated with greater patient satisfaction, adherence and in rating the 
prescriber as more empathic. While it is acknowledged that discussing 
treatment options or asking the patient’s preference for treatment are 
skills which may not need to be demonstrated in every consultation, such 
a low frequency of occurrence suggests they are unlikely to be a routine 
part of consultation practice for most prescribers. 
 
These findings have similarities with Latter et al’s (2007) study of nurse 
prescribers. They found that, while almost all nurses (99%) self reported 
that they practised concordance, during observed consultations it was 
found that in only 39% of consultations were the benefits and risks of 
treatment options explained. However, in other aspects of involvement 
(explaining the condition, checking the patient’s understanding) they did 
well (Latter et al., 2007). In a study of nurse prescribers working in 
diabetes care, Sibley et al. (2011) recorded 59 nurse prescriber – patient 
consultations in which there were 260 medicines discussions. The most 
frequent theme, ‘medication named’ was found in 89% (231/260) of the 
medicines discussion whereas asking the patient’s opinion was mentioned 
Comparing GP, nurse and pharmacist prescribers 
 22 
infrequently (20%, 51/260) and giving the reasons for the medication 
discussed rarely (8.5%, 22/260) (Sibley, et al., 2011). Both of these 
studies support earlier research with 20 GPs which found little evidence of 
the first two characteristics necessary for shared decision making, namely 
that both the doctor and patient are involved in decision making and that 
both share information (Stevenson et al., 2000).   
 
In terms of differences between prescribers, these findings (Table 7) 
suggest that pharmacist prescribers may be better at some medicine-
related tasks, such as asking for the patient’s preference and in giving 
treatment options, than either nurse prescribers or GPs. This could be due 
to the types of patients pharmacist prescribers see, such that pharmacists 
are more likely, due to their professional background, to see patients 
where a medication issue is discussed. Nonetheless, the level of asking 
the patient their preference and providing options was still low (25% and 
32%, respectively). Greenhill et al. (2011) similarly reported a low level 
amongst pharmacists of the skills relevant to encouraging patient 
participation in the consultation, although they only investigated 18 
consultations across five pharmacists, who were not pharmacist 
prescribers. In contrast, in Courtenay et al.’s (2011) qualitative study with 
dermatology patients of nurse prescribers, patients reported being actively 
involved in their treatment decision-making and felt their views were 
incorporated into treatment plans. Similar findings using self-report were 
found in Knapp et al.’s study of pre-registration pharmacists, medical and 
nursing students’ attitudes to partnership in medicine taking. They found 
that nursing students were significantly more in agreement with the 
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concept of concordance compared with medical students and pre-
registration pharmacists (Knapp, et al., 2009). Finally, in their study of 
family physicians in Canada, Towle et al. (2006) found that competencies 
in partnership (encouraging the patient to be involved in the decision) and 
ideas (asking the patient their thoughts about choices) were observed in 
most consultations. However, in a follow-up discussion group, physicians 
considered the competency of partnership problematic, having difficulty in 
trusting the patient to behave responsibly when they felt a sense of 
responsibility for them (Towle et al., 2006). It is likely that these concerns 
about partnership are relevant for nurse and pharmacist prescribers as 
well. 
 
Also of note was the higher level of satisfaction of patients of nurse 
prescribers compared with patients of GPs and pharmacist prescribers. In 
Drennan et al.’s (2011) study of hospital nurse prescribers in Ireland, 
which similarly used the Baker Consultation Satisfaction Questionnaire, 
high levels of patient satisfaction were found. Drennan et al. provide mean 
satisfaction scores for three of the four sub-scales (e.g. the depth of 
relationship sub scale was omitted). Converting their findings to be 
comparable with ours, this results in strikingly similar satisfaction scores, 
with our findings of 4.31, 3.79 and 4.29 on the professional care, 
perceived time and general satisfaction scales (Table 9), nearly identical 
with Drennan et al.’s corresponding findings of 4.51, 3.78 and 4.29. 
Similarly, comparing these findings with those of Baker (1990) for GPs 
(and converting the scales so they are comparable), our findings of 4.01, 
4.13, 3.67 and 3.58 on the general satisfaction, professional care, depth 
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of relationship and perceived time sub-scales are considerably higher than 
those found in 1990 which were 2.95, 3.01, 2.5 and 2.53, respectively, 
reflecting, potentially, greater satisfaction with care 20 years later.  
 
One of the few previous studies comparing patient satisfaction across 
professional groups similarly found a higher level of patient satisfaction 
with nurse practitioners in primary care compared with GPs (Seale et al, 
2005). Seale et al. explained their findings as being due to the increased 
provision of information in nurse practitioner consultations, as well as the 
longer consultation length, neither of which were found to be significant in 
this research.  
 
Our findings are in agreement with previous research which found that 
younger people and women were more like to prefer a more active role in 
decision making (Robinson & Thomson, 2001; Say et al., 2006; Cullati et 
al., 2010). Yet only 44% of our patients completing the questionnaire 
preferred an active or collaborative role in decision making. This is in 
contrast to findings of Chewning et al (2012) who found that, in studies 
published in or after 2000 in general practice populations, the majority of 
patients favoured a more active role in decision making in 59% of the 
studies reviewed. Although Chewning et al (2012) also found that British 
patients were more passive than patients from the US. However, in 
comparing expectations with actual experience, the majority of patients 
(66%) did receive the level of involvement in decision making that they 
thought should occur. This is in contrast to Cox et al.’s study (2007) 
where GPs accurately assessed the patient’s level of involvement in only 
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32% of the consultations, with GPs overestimating the patient’s 
preference for involvement in 45% of the consultations. While other 
authors (Krupat et al., 2000) have suggested that patient satisfaction 
declines when the orientation of the doctor differs from the orientation of 
the patient, particularly when the patient is more patient centred than the 
doctor, we found no difference in patient satisfaction between those 
whose experienced role matched their expectations compared with those 
where it did not.      
 
Limitations 
While there were initially 533 consultations, this only represented 
consultations from 12 pharmacist prescribers (as they were difficult to 
recruit). Further, when the sample was reduced to match prescribing 
decisions with returned patient questionnaires, the resulting number of 
matched consultations (192) was relatively small; the findings are drawn 
from, in particular, a small number of pharmacists which may not be 
generalisable to the wider prescriber population. Also, due to the number 
of statistical tests performed, a significance level of p<0.05 may have 
been too generous, with the results prone to type 1 error due to multiple 
testing. An important caveat is also related to the context in terms of the 
clinical conditions observed. One reason why there may have been a low 
level of discussion about medication decision preferences may be because 
either there were few options available for that clinical decision or that the 
discussion involved a repeat prescription where options were unlikely to 
be discussed. Given the wide range of methods for capturing shared 
decision making, this research used a method which was very task or 
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transaction focused (Epstein and Street, 2011) in terms of describing the 
decision making process. This is just one way to measure the decision 
making process and it is recognised that there may be other, better ways 
of describing decision making which would have led to different findings.  
In addition, although we could record whether we thought, for example, 
the expression of options had occurred, previous research has suggested 
that there is a difference between observer descriptions or ratings of 
shared decision making and the patient’s experience of it (Edwards and 
Elwyn, 2006; Wunderlich et al., 2010). Therefore we do not know whether 
our process for capturing the decision making process was what the 
patient experienced. We also did not have access to video and therefore 
have no knowledge of the patient’s body language or other non verbal 
features of the interaction which could have informed how we coded the 
data.  
 
This paper focused quite narrowly on the treatment decision making 
process and it is recognised that a more holistic approach to analysing 
consultations, including assessing the patients’ ideas, concerns and 
expectations, are vital aspects of the shared decision making process. This 
is particularly relevant given the findings that patient perceptions of 
practitioner empathy were so strongly associated with patient satisfaction. 
Other aspects of the consultation from this research, including prescriber 
responses to patients’ cues and concerns and their use of an opening 
solicitation, have been published elsewhere (Riley et al., 2012; Weiss et 
al., 2013). An important limitation was that, for simplicity of analysis, we 
only used the first decision discussed in the consultation and matched this 
Comparing GP, nurse and pharmacist prescribers 
 27 
with the patient survey data. Subsequent decisions may have related 
differently to the patient outcome data. In addition, we did not record the 
number of medications patients were taking, which may be an important 
covariate, and our measure of adherence was self-report which may not 
reflect actual patient behaviour. Finally, we accept that consultation length 
is a key confounder in these findings. Although consultation length did not 
affect patient satisfaction, pharmacist prescribers did have significantly 
longer consultations and this could have influenced their willingness and 
perceived sense of space in the consultation to discuss options and 
treatment rationales within the consultation.  
 
Conclusion 
This paper explored elements of the shared decision making process 
through a comparison of GPs, nurse and pharmacist prescribers. The 
findings underline the relatively low level at which shared decision making 
is occurring, even from those new prescribers likely to have had their 
training relatively recently. The findings also suggest that pharmacist 
prescribers may exhibit the tasks around giving options and asking the 
patient’s preference slightly more often than nurse prescribers or GPs; 
perhaps because of their traditional role associated with medicines. In 
addition, patients of nurse prescribers were more satisfied, giving 
satisfaction scores strikingly similar to previous research with nurse 
prescribers in secondary care. Interestingly, across all prescriber groups, 
as the length of time a prescriber spent giving treatment options 
increased, so did patient satisfaction, adherence and patient perceptions 
of the prescriber’s empathy. While acknowledging the limitations of trying 
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to measure such a complex process, these findings suggest that engaging 
in shared decision making can have some benefit. Yet measurement 
remains an issue. Defining the activities, tasks or competencies associated 
with shared decision making, which can also be measured, remains 
elusive. Developing tools which capture shared decision making tasks such 
as ‘deals sensitively with emotions’ or ‘creates a relationship which does 
not encourage the expectation of a prescription’ are challenging to 
operationalise. Nonetheless the shared decision making community needs 
to persist in its efforts towards understanding, describing and enabling 
these processes, to fully elucidate possible benefits to the patient.  
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Table 1: Shared Decision Making Competencies  
(with parents, care-givers or advocates where appropriate)* 
 
Establishes a relationship based on trust and mutual respect. Recognises 
patients as partners in the consultation. 
1. Identifies and respects the patient’s values, beliefs and expectations 
about medicines. 
2. Takes into account the nature of peoples’ diversity when prescribing. 
3. Undertakes the consultation in an appropriate setting taking account of 
confidentially, dignity and respect. 
4. Adapts consultations to meet needs of different patients (e.g. for 
language, age, capacity, physical or sensory impairments). 
5. Deals sensitively with patients’ emotions and concerns about their 
medicines. 
6. Creates a relationship which does not encourage the expectation that a 
prescription will be supplied. 
7. Explains the rationale behind and the potential risks and benefits of 
management options. 
8. Works with patients to make informed choices about their management 
and respects their right to refuse or limit treatment. 
9. Aims for an outcome of the consultation with which the patient and 
prescriber are satisfied. 
10. When possible, supports patients to take responsibility for their 
medicines and self-manage their conditions. 
11. Gives the patient clear accessible information about their medicines 
(e.g. what it is for, how to use it, where to get it from, possible unwanted 
effects). 
12. Checks patient’s understanding of and commitment to their 
management, monitoring and follow-up. 
13. Understands the different reasons for non-adherence to medicines 
(practical and behavioural) and how best to support patients. Routinely 
assessed adherence in a non-judgemental way. 
 
 
* Taken from the National Prescribing Centre. A Single Competency 
Framework for all prescribers. 
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Table 2: (Selected) Information Collected about each Prescribing Decision 
Information Collected How recorded Information Collected How recorded 
Did the prescriber elicit information about medicines 
the patient already taking? (pre-decision) 
Yes/No Did the prescriber clearly state the 
outcome of the decision regarding 
the medicine? (the decision) 
Yes/No 
Did the prescriber offer a rationale about a 
proposed medicine? (pre-decision) 
Yes/No Did the prescriber give a rationale 
for the treatment preference (post 
decision) 
Yes/No 
Did the prescriber give the patient options about the 
medicines / treatment? (pre-decision) 
Yes/No Length of time the prescriber 
provided a rationale post decision 
Start / stop of 
talk concerning 
post decision 
rationale 
Length of time the prescriber described possible 
treatment options (pre-decision) 
Start / stop of 
talk on options 
Patient response to the decision Positive / 
Neutral / 
Negative / No 
response 
Did the prescriber ask the patient for their 
preference about the medication regimen? (pre-
decision) 
Yes/No Did the patient ask questions post 
decision? 
Yes/No 
Did the patient express a treatment or medicine 
preference? (pre-decision) 
Yes/No Was the decision changed as a 
result of post decision discussion? 
Yes/No 
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Table 3: Statements and Sub-scales within the Satisfaction Scale [14] 
 
General Satisfaction* 
1. I am totally satisfied with my visit to this prescriber**. 
7. Some things about my consultation with the prescriber could have been better. 
17. I am not completely satisfied with my visit to the prescriber. 
Professional Care* 
2. This prescriber was very careful to check everything when examining me. 
3. I will follow this prescriber’s advice because I think he/she is absolutely right. 
6. This prescriber told me everything about my treatment. 
9. This prescriber examined me very thoroughly. 
10. I thought this prescriber took notice of me as a person. 
12. I understand my illness / condition much better after seeing this prescriber 
13. This prescriber was interested in me as a person, and not just my illness / 
condition. 
Depth of Relationship* 
4. I felt able to tell this prescriber about very personal things. 
8. There are some things this prescriber does not know about me. 
14. This prescriber knows all about me. 
15. I felt this prescriber really knew what I was thinking. 
18. I would find it difficult to tell this prescriber about some private things. 
Perceived Time* 
5. The time I was able to spend with the prescriber was a bit too short. 
11. The time I was allowed to spend with the prescriber was not long enough to deal 
with everything I wanted. 
16. I wish it had been possible to spend a bit longer with the prescriber. 
 
* Individual items within each sub-scale were reversed where appropriate such 
that higher satisfaction scores equalled greater satisfaction. 
** The type of prescriber (GP, nurse or pharmacist) was substituted here in the 
different versions of the questionnaire. 
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Table 4: Demographic and Descriptive Characteristics of Prescribers 
Professional 
Group 
Number of 
prescribers 
Number of 
consultations 
Number Male Mean Age 
(standard 
deviation) 
Median 
Consultation 
Length 
(minutes) 
Total 
General Practitioners 20 213 12 49 (5.4) 9.96 213 
Nurse Prescribers 19 209 0 46 (6.3) 9.92 209 
Pharmacist 
Prescribers 
12 111 4 42 (6.4) 15.75 111 
Total 51 533 16 47 (6.6) 10.8 533 
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Table 5: Number of Prescribing Decisions by Consultation 
 
Number of 
Prescribing 
Decisions 
Number of 
Consultations 
(N=533) 
0 112 
1 366 
2 49 
3 6 
 
 
Comparing GP, nurse and pharmacist prescribers 
 39 
Table 6: Examples of Prescribing Decisions Made in the 
Consultations 
 
 
  
GP (42): “So I’m giving you naproxen for your shoulder and 
omeprazole for your stomach and I’ll refer you to XXX” 
 
GP (673): “It’s quite important that you keep taking it – the 
amlodipine. Are you happy to carry on with it?” 
  
PP (943): “ So what I’m going to do is start you on 55 (units, of 
insulin) and build you up, yes?” 
 
PP (590): “Let’s take up the dose of the candesartan to 16mg, that’s 
the next step up, I know that sounds a lot…” 
 
NP (151): “What I'm going to try is something called Volterol which is a 
similar kind of drug to Brufen but the next one up.”       
 
NP (236): “So, I agree with you completely, I don't think you need any 
more antibiotics. What I will get for you is an inhaler.”                                                                                                                                                                                                                                                                   
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Table 7: Tasks undertaken in Prescribing Decisions by Prescriber Type 
 
 GP 
prescribing 
decisions 
N (%) 
Nurse 
Prescriber 
prescribing 
decisions 
N (%) 
Pharmacist 
Prescriber 
prescribing decisions  
N (%) 
Total Prescribing Decisions 
Patient given treatment 
options* 
44 (20%) 26 (16%) 32 (32%) 102 (21%) 
Prescriber asked the patient 
their preference about 
medication regimen* 
43 (19%) 20 (13%) 25 (25%) 88 (18%) 
Patient expressed a 
treatment preference 
57 (26%) 30 (19%) 31 (31%) 118 (24%) 
Prescriber provided a 
rational for a treatment pre-
decision 
60 (27%) 39 (25%) 38 (38%) 137 (28%) 
Patient asked questions* 71 (32%) 34 (22%) 19 (19%) 124 (26%)** 
Total decisions 223 159 100 482 
 
 *Significantly different across the prescriber groups at < 0.05% (see text) 
 ** Four missing values such that total N=478 
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Table 8: Demographic Background of Patients Completing Questionnaire by Prescriber Type (N=275) 
 
Patient Characteristics GP Patients Nurse Prescriber 
Patients 
Pharmacist 
Prescriber Patients 
All Responding 
Patients 
Number Male (%)* 44 (38%) 27 (27%) 31 (55%) 102 (37%) 
Ethnicity: Number White 
British (%)**  
114 (99%) 101 (100%) 53 (96%) 268 (99%) 
Mean Age (SD)*** 59 (15.8) 53 (20.1) 69 (11.3) 59.3 (17.7) 
Number left full-time 
education age 18 or less 
(%)**** 
69 (60%) 43 (43%) 40 (71%) 152 (56%) 
Total 117 101 57 275 
 
*Missing data from two respondents 
**Missing data from four respondents 
***Missing data from 12 respondents 
****Missing data from three respondents 
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Table 9: Patient Satisfaction Scores by Prescriber Type 
 
Satisfaction 
Sub Scale 
Type of 
Prescriber 
Total 
N 
Mean 
Satisfaction 
Score (SD) 
Range*** Median 
Satisfaction 
Score 
Comparison 
between 
Prescribers 
Sig* 
General 
Satisfaction 
GP 110 4.01 (0.68) 1.67-5.00 4.0 GP v NP 0.001** 
NP  99 4.29 (0.55) 2.00-5.00 4.33 GP v PP 0.99 
PP 53 4.04 (0.62) 2.33-5.00 4.0 NP v PP 0.006** 
Professional 
Care 
GP 109 4.13 (0.58) 2.14-5.00 4.14 GP v NP 0.020** 
NP  99 4.31 (0.55) 2.57-5.00 4.40 GP v PP 0.997 
PP 52 4.15 (0.52) 3.00-5.00 4.07 NP v PP 0.037** 
Depth of 
Relationship 
GP 111 3.67 (0.74) 1.80-5.00 3.66 GP v NP 0.81 
NP  97 3.71 (0.72) 2.00-5.00 3.60 GP v PP 0.14 
PP 50 3.46 (0.64) 1.33-4.60 3.60 NP v PP 0.084 
Perceived Time GP 113 3.58 (0.95) 1.00-5.00 4.0 GP v NP 0.11 
NP  98 3.79 (0.73) 1.67-5.00 4.0 GP v PP 0.75 
PP 53 3.66 (0.77) 1.00-5.00 4.0 NP v PP 0.093 
 
* Comparisons between prescriber groups using a Mann-Whitney U Test 
** Significant at p<0.05. Higher scores indicate greater satisfaction 
*** Satisfaction scores were a percentage out of 100 with5 being the maximal score of 100%. These were determined 
regardless of the number of items completed. For this reason the values for the range are not necessarily whole numbers.   
 
Comparing GP, nurse and pharmacist prescribers 
 43 
Table 10: Correlations between Different Patient Outcomes (N=275)* 
 
Outcome General 
Satisfaction 
 
Satisfaction 
Professional 
Care  
Satisfaction 
– Depth of 
Relationship  
Satisfaction 
– Perceived 
Time 
Total 
Empathy 
Score 
Total 
Adherence 
Score 
Consultation 
Length 
General 
Satisfaction 
1.0 
- 
262 
      
Satisfaction – 
Professional 
Care  
0.47*** 
p<0.0001 
252 
1.0 
- 
260 
     
Satisfaction – 
Depth of 
Relationship 
0.43*** 
p<0.0001 
251 
0.55*** 
p<0.0001 
248 
1.0 
- 
258 
    
Satisfaction – 
Perceived 
Time 
0.47*** 
p<0.0001 
259 
0.16** 
p=0.013 
256 
0.16** 
p=0.01 
253 
1.0 
- 
264 
   
Total 
Empathy 
Score 
0.46*** 
p<0.0001 
200 
0.64*** 
p<0.0001 
203 
0.53*** 
p<0.0001 
200 
0.14** 
p=0.047 
203 
1.0 
- 
207 
  
Total 
Adherence 
Score 
0.05 
p=0.45 
246 
-0.005 
p=0.94 
244 
-0.047 
p=0.46 
243 
-0.016 
p=0.81 
248 
0.063 
p=0.39 
195 
1.0 
- 
255 
 
Consultation 
Length 
-0.073 
p=0.33 
183 
-0.04 
p=0.56 
184 
-0.073 
p=0.33 
180 
-0.082 
p=0.27 
185 
-0.087 
p=0.29 
149 
0.065 
p=0.38 
180 
1.0 
- 
193 
 
* Values shown are Spearman’s rho correlation coefficient, the significance level and number of respondents 
** Significant at a level of < 0.05 
*** Significant at a level of < 0.01 
